Russia is offering doses of its Sputnik V vaccine against COVID-19 to the EU in order to compensate for the shortages of other vaccines, which have failed to be delivered.
The public investment fund that co-finances and sells the vaccine said that Russia would be able to supply 100 million doses of Sputnik V to the European Union by the spring.
With these doses, 50 million EU citizens would be able to receive the two shots needed to be vaccinated.
Russia has already fully vaccinated about 1.5 million of its 140 million population, however, Sputnik V cannot be administered in the EU until it is approved by the European Medicines Agency, which is currently in the process of analyzing it.
According to the Sputnik V manufacturers, the vaccine has already been approved in 15 countries across the globe, with Hungary as its first EU member state to approve it.
While Russia permitted the administration of the vaccine back in August, no results of independent studies about its efficacy have been published yet.